UY34128A - Métodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih)?. - Google Patents

Métodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih)?.

Info

Publication number
UY34128A
UY34128A UY0001034128A UY34128A UY34128A UY 34128 A UY34128 A UY 34128A UY 0001034128 A UY0001034128 A UY 0001034128A UY 34128 A UY34128 A UY 34128A UY 34128 A UY34128 A UY 34128A
Authority
UY
Uruguay
Prior art keywords
hiv
kits
virus
compositions
methods
Prior art date
Application number
UY0001034128A
Other languages
English (en)
Inventor
Wronska Danuta
Tremlett Leslie
Schouest Katherine
Original Assignee
Grifols Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Therapeutics Inc filed Critical Grifols Therapeutics Inc
Publication of UY34128A publication Critical patent/UY34128A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Abstract

La presente invención se refiere a composiciones, procedimientos y kits para determinar la presencia o ausencia de VIH en una muestra, en particular para determinar VIH-1 del grupo M, VIH-1 del grupo O y/o VIH-2, 10 en particular para determinar de forma simultánea VIH-1 del grupo M, VIH-1 del grupo O y VIH-2.
UY0001034128A 2011-06-15 2012-06-14 Métodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih)?. UY34128A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161497234P 2011-06-15 2011-06-15

Publications (1)

Publication Number Publication Date
UY34128A true UY34128A (es) 2013-01-31

Family

ID=47357719

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034128A UY34128A (es) 2011-06-15 2012-06-14 Métodos, composiciones y kits para determinar el virus de la inmunodeficiencia humana (vih)?.

Country Status (14)

Country Link
US (1) US9273366B2 (es)
EP (1) EP2643460B1 (es)
CN (1) CN103635575B (es)
AR (1) AR086925A1 (es)
AU (1) AU2012271672B2 (es)
BR (1) BR112013032223A2 (es)
ES (1) ES2644839T3 (es)
HU (1) HUE036963T2 (es)
MX (1) MX340053B (es)
PL (1) PL2643460T3 (es)
PT (1) PT2643460T (es)
RU (1) RU2584573C2 (es)
UY (1) UY34128A (es)
WO (1) WO2012174187A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10113206B2 (en) * 2010-02-24 2018-10-30 Grifols Therapeutics Inc. Methods, compositions, and kits for determining human immunodeficiency virus (HIV)
ES2864855T3 (es) 2014-07-24 2021-10-14 Abbott Molecular Inc Métodos para la detección y análisis de mycobacterium tuberculosis
EP3322483A4 (en) 2015-07-14 2019-01-02 Abbott Molecular Inc. Compositions and methods for identifying drug resistant tuberculosis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4605735A (en) 1983-02-14 1986-08-12 Wakunaga Seiyaku Kabushiki Kaisha Oligonucleotide derivatives
US4757141A (en) 1985-08-26 1988-07-12 Applied Biosystems, Incorporated Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US4826967A (en) 1987-06-16 1989-05-02 Naxcor Psoralen-nucleoside adducts and method for their preparation
US5082934A (en) 1989-04-05 1992-01-21 Naxcor Coumarin derivatives for use as nucleotide crosslinking reagents
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5847096A (en) * 1991-08-30 1998-12-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services DNA constructs encoding CD4 fusion proteins
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
CA2222769C (en) * 1997-01-17 2001-06-12 F. Hoffmann-La Roche Ag Primers for the detection of hiv-1
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
CA2333901A1 (en) * 1998-08-03 2000-02-24 East Carolina University Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
TR200604211T1 (tr) 1999-02-12 2007-02-21 Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited Yeni nükleosid ve oligonükleotid analoglarıYeni nükleosid ve oligonükleotid analogları
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US20040121335A1 (en) * 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
CN101072882A (zh) * 2004-09-10 2007-11-14 塞昆纳姆股份有限公司 用于核酸长程序列分析的方法
WO2007073149A1 (en) * 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
KR20080037128A (ko) * 2006-10-25 2008-04-30 주식회사 씨젠 뉴클레오타이드 변이 검출 방법
EP2376651A2 (en) * 2008-12-19 2011-10-19 Abbott Laboratories Molecular assay for diagnosis of hiv tropism

Also Published As

Publication number Publication date
PT2643460T (pt) 2017-10-24
EP2643460B1 (en) 2017-07-26
EP2643460A4 (en) 2014-05-21
HUE036963T2 (hu) 2018-08-28
WO2012174187A2 (en) 2012-12-20
RU2584573C2 (ru) 2016-05-20
MX340053B (es) 2016-06-22
AU2012271672A1 (en) 2013-05-02
EP2643460A2 (en) 2013-10-02
CN103635575A (zh) 2014-03-12
US20140120526A1 (en) 2014-05-01
AU2012271672B2 (en) 2016-02-18
ES2644839T3 (es) 2017-11-30
BR112013032223A2 (pt) 2016-12-20
CN103635575B (zh) 2019-03-01
PL2643460T3 (pl) 2018-01-31
WO2012174187A3 (en) 2013-03-28
RU2013151821A (ru) 2015-05-27
AR086925A1 (es) 2014-01-29
US9273366B2 (en) 2016-03-01
MX2013013293A (es) 2013-12-12

Similar Documents

Publication Publication Date Title
CL2016002455A1 (es) Anticuerpos multiespecíficos.
DOP2017000078A (es) Indazoles sustituidos con bencilo como inhibidores de bub1.
UY34824A (es) Nucleósidos de espirooxetano de uracilo
CR20160419A (es) Nuevos compuestos biciclicos
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
UY34697A (es) Métodos para preparar análogos de nucleótidos
EA201401077A1 (ru) Биспецифические антитела к человеческому tweak и человеческому il17 и их применения
CR20140460A (es) Formas polimórficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluoro-3-fenilquinazolin-4(3h)-ona
EA201491811A1 (ru) АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ
UA113651C2 (xx) Макроциклічні пурини для лікування вірусних інфекцій
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
UY34472A (es) Derivados modificados de 4-fenil-piridina
EA202090547A3 (ru) Макроциклические деаза-оксипурины для лечения вирусных инфекций
EA201491947A1 (ru) Антитела и иммуноконъюгаты к ly6e и способы применения
NI201400079A (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
BR112017000456A2 (pt) composições antivirais tópicas e métodos de uso das mesmas
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA201590887A1 (ru) Композиция
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201691945A1 (ru) Антитела к гемагглютинину вируса гриппа типа b и способы их применения
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220104